{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:26:27Z","timestamp":1771010787264,"version":"3.50.1"},"reference-count":32,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.1620\/tjem.231.75","type":"journal-article","created":{"date-parts":[[2013,9,28]],"date-time":"2013-09-28T02:02:50Z","timestamp":1380333770000},"page":"75-84","source":"Crossref","is-referenced-by-count":10,"title":["A 68-Year-Old Phenotypically Male Patient with 21-Hydroxylase Deficiency and Concomitant Adrenocortical Neoplasm Producing Testosterone and Cortisol"],"prefix":"10.1620","volume":"231","author":[{"given":"Masayuki","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Chukyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Chukyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Sugimura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Field of Internal Medicine, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, National Research Institute for Child Health and Development"},{"name":"Department of Pediatrics, Hamamatsu University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Fukami","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, National Research Institute for Child Health and Development"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology, National Research Institute for Child Health and Development"},{"name":"Department of Pediatrics, Hamamatsu University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Homma","sequence":"additional","affiliation":[{"name":"Central Clinical Laboratories, Keio University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Oiso","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, Field of Internal Medicine, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Chukyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"Abo, K., Sumino, K., Nishio, H., Hozumi, T., Ishida, Y., Fujieda, K., Tajima, T. &amp; Kazumi, T. (1999) 21-Hydroxylase deficiency presenting as massive bilateral adrenal masses in the seventh decade of life. <i>Endocr. J.<\/i>, 46, 817-823."},{"key":"2","unstructured":"Bachelot, A., Chakthoura, Z., Rouxel, A., Dulon, J. &amp; Touraine, P. (2008) Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults. <i>Horm. Res.<\/i>, 69, 203-211."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bauman, A. &amp; Bauman, C.G. (1982) Virilizing adrenocortical carcinoma. Development in a patient with salt-losing congenital adrenal hyperplasia. <i>JAMA<\/i>, 248, 3140-3141.","DOI":"10.1001\/jama.1982.03330230052032"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Carroll, M.C., Campbell, R.D. &amp; Porter, R.R. (1985) Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. <i>Proc. Natl. Acad. Sci. USA<\/i>, 82, 521-525.","DOI":"10.1073\/pnas.82.2.521"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Dufort, I., Rheault, P., Huang, X.F., Soucy, P. &amp; Luu-The, V. (1999) Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. <i>Endocrinology<\/i>, 140, 568-574.","DOI":"10.1210\/endo.140.2.6531"},{"key":"6","unstructured":"Hamwi, G.J., Serbin, R.A. &amp; Kruger, F.A. (1957) Does adrenocortical hyperplasia result in adrenocortical carcinoma. <i>N. Engl. J. Med.<\/i>, 257, 1153-1157."},{"key":"7","doi-asserted-by":"crossref","unstructured":"Higashi, Y., Tanae, A., Inoue, H., Hiromasa, T. &amp; Fujii-Kuriyama, Y. (1988) Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. <i>Proc. Natl. Acad. Sci. USA<\/i>, 85, 7486-7490.","DOI":"10.1073\/pnas.85.20.7486"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Homma, K., Hasegawa, T., Masumoto, M., Takeshita, E., Watanabe, K., Chiba, H., Kurosawa, T., Takahashi, T. &amp; Matsuo, N. (2003) Reference values for urinary steroids in Japanese newborn infants: gas chromatography\/mass spectrometry in selected ion monitoring. <i>Endocr. J.<\/i>, 50, 783-792.","DOI":"10.1507\/endocrj.50.783"},{"key":"9","unstructured":"Homma, K., Hasegawa, T., Takeshita, E., Watanabe, K., Anzo, M., Toyoura, T., Jinno, K., Ohashi, T., Hamajima, T., Takahashi, Y., Takahashi, T. &amp; Matsuo, N. (2004) Elevated urine pregnanetriolone definitively establishes the diagnosis of classical 21-hydroxylase deficiency in term and preterm neonates. <i>J. Clin. Endocrinol. Metab.<\/i>, 89, 6087-6091."},{"key":"10","unstructured":"Iino, K., Sasano, H., Yabuki, N., Oki, Y., Kikuchi, A., Yoshimi, T. &amp; Nagura, H. (1997) DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas. <i>Mod. Pathol.<\/i>, 10, 901-907."},{"key":"11","unstructured":"Jaresch, S., Kornely, E., Kley, H.K. &amp; Schlaghecke, R. (1992) Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. <i>J. Clin. Endocrinol. Metab.<\/i>, 74, 685-689."},{"key":"12","unstructured":"Jaursch-Hancke, C., Allolio, B., Metzler, U., Bidlingmaier, F. &amp; Winkelmann, W. (1988) Adrenocortical carcinoma in a patient with untreated congenital adrenal hyperplasia (CAH). <i>Acta Endocrinologica (Copenh)<\/i>, 117, Suppl., 287, 146-147."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Koyama, S., Toyoura, T., Saisho, S., Shimozawa, K. &amp; Yata, J. (2002) Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. <i>J. Clin. Endocrinol. Metab.<\/i>, 87, 2668-2673.","DOI":"10.1210\/jcem.87.6.8522"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Koyama, Y., Homma, K., Fukami, M., Miwa, M., Ikeda, K., Ogata, T., Hasegawa, T. &amp; Murata, M. (2012) Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone\/ tetrahydroxycortisone ratio and 11<i>\u03b2<\/i>-hydroxyandrosterone. <i>Clin. Chem.<\/i>, 58, 741-747.","DOI":"10.1373\/clinchem.2011.173286"},{"key":"15","unstructured":"Krone, N., Braun, A., Roscher, A.A., Knorr, D. &amp; Schwarz, H.P. (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. <i>J. Clin. Endocrinol. Metab.<\/i>, 85, 1059-1065"},{"key":"16","unstructured":"Lee, P.A. &amp; Houk, C.P. (2010) Review of outcome information in 46,XX patients with congenital adrenal hyperplasia assigned\/reared male: what does it Say about gender assignment? <i>Int. J. Pediatr. Endocrinol.<\/i>, 2010, 982025."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Lorence, M.C., Murry, B.A., Trant, J.M. &amp; Mason, J.I. (1990) Human 3 beta-hydroxysteroid dehydrogenase\/delta 5\u20144isomerase from placenta: expression in nonsteroidogenic cells of a protein that catalyzes the dehydrogenation\/isomerization of C21 and C19 steroids. <i>Endocrinology<\/i>, 126, 2493-2498.","DOI":"10.1210\/endo-126-5-2493"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Merke, D.P. &amp; Bornstein, S.R. (2005) Congenital adrenal hyperplasia. <i>Lancet<\/i>, 365, 2125-2136.","DOI":"10.1016\/S0140-6736(05)66736-0"},{"key":"19","unstructured":"Nagasaka, S., Kubota, K., Motegi, T., Hayashi, E., Ohta, M., Takahashi, K., Takahashi, T., Iwasaki, Y., Koike, M. &amp; Nishikawa, T. (1996) A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma. <i>Clin. Endocrinol. (Oxf.)<\/i>, 44, 111-116."},{"key":"20","unstructured":"Nakamura, Y., Hornsby, P.J., Casson, P., Morimoto, R., Satoh, F., Xing, Y., Kennedy, M.R., Sasano, H. &amp; Rainey, W.E. (2009) Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. <i>J. Clin. Endocrinol. Metab.<\/i>, 94, 2192-2198."},{"key":"21","unstructured":"Nakazumi, H., Sasano, H., Iino, K., Ohashi, Y. &amp; Orikasa, S. (1998) Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. <i>Mod. Pathol.<\/i>, 11, 1165-1170."},{"key":"22","doi-asserted-by":"crossref","unstructured":"Nimkarn, S., Lin-Su, K. &amp; New, M.I. (2011) Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia. <i>Pediatr. Clin. North Am.<\/i>, 58, 1281-1300, xii.","DOI":"10.1016\/j.pcl.2011.07.012"},{"key":"23","unstructured":"Sasano, H., Miyazaki, S., Sawai, T., Sasano, N., Nagura, H., Funahashi, H., Aiba, M. &amp; Demura, H. (1992) Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. <i>Mod. Pathol.<\/i>, 5, 23-29."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Shinagawa, T., Horikawa, R., Isojima, T., Naiki, Y., Tanaka, T. &amp; Katsumata, N. (2007) Nonclassic steroid 21-hydroxylase deficiency due to a homozygous V281L mutation in CYP21A2 detected by the neonatal mass-screening program in Japan. <i>Endocr. J.<\/i>, 54, 1021-1025.","DOI":"10.1507\/endocrj.K07-028"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Stikkelbroeck, N.M., Hoefsloot, L.H., de Wijs, I.J., Otten, B.J., Hermus, A.R. &amp; Sistermans, E.A. (2003) CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. <i>J. Clin. Endocrinol. Metab.<\/i>, 88, 3852-3859.","DOI":"10.1210\/jc.2002-021681"},{"key":"26","unstructured":"Usui, T., Nishisho, K., Kaji, M., Ikuno, N., Yorifuji, T., Yasuda, T., Kuzuya, H. &amp; Shimatsu, A. (2004) Three novel mutations in Japanese patients with 21-hydroxylase deficiency. <i>Horm. Res.<\/i>, 61, 126-132."},{"key":"27","unstructured":"Wedell, A., Thilen, A., Ritzen, E.M., Stengler, B. &amp; Luthman, H. (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. <i>J. Clin. Endocrinol. Metab.<\/i>, 78, 1145-1152."},{"key":"28","unstructured":"Weiss, L.M. (1984) Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. <i>Am. J. Surg. Pathol.<\/i>, 8, 163-169."},{"key":"29","doi-asserted-by":"crossref","unstructured":"White, P.C., Grossberger, D., Onufer, B.J., Chaplin, D.D., New, M.I., Dupont, B. &amp; Strominger, J.L. (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. <i>Proc. Natl. Acad. Sci. USA<\/i>, 82, 1089-1093.","DOI":"10.1073\/pnas.82.4.1089"},{"key":"30","doi-asserted-by":"crossref","unstructured":"White, P.C., New, M.I. &amp; Dupont, B. (1984) Cloning and expression of cDNA encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation. <i>Proc. Natl. Acad. Sci. USA<\/i>, 81, 1986-1990.","DOI":"10.1073\/pnas.81.7.1986"},{"key":"31","unstructured":"Wilson, R.C., Mercado, A.B., Cheng, K.C. &amp; New, M.I. (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. <i>J. Clin. Endocrinol. Metab.<\/i>, 80, 2322-2329."},{"key":"32","unstructured":"Zhang, H.J., Yang, J., Zhang, M.N., Zhang, W., Liu, J.M., Wang, W.Q., Ning, G. &amp; Li, X.Y. (2009) Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21-hydroxylase deficiency. <i>Clin. Endocrinol. (Oxf.)<\/i>, 70, 201-207."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/231\/2\/231_75\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T19:56:47Z","timestamp":1619639807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/231\/2\/231_75\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.231.75","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}